DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Needham Maintains Buy on GenMark Diagnostics, Lowers Price Target to $11

Needham maintains GenMark Diagnostics (NASDAQ:GNMK) with a Buy and lowers the price target from $12 to $11.

Benzinga · 03/03/2020 12:04

Needham maintains GenMark Diagnostics (NASDAQ:GNMK) with a Buy and lowers the price target from $12 to $11.